Counterpoint Mutual Funds LLC Makes New Investment in Trupanion, Inc. (NASDAQ:TRUP)

Counterpoint Mutual Funds LLC bought a new position in Trupanion, Inc. (NASDAQ:TRUP) during the fourth quarter, Holdings Channel.com reports. The institutional investor bought 5,455 shares of the financial services provider’s stock, valued at approximately $263,000.

A number of other institutional investors have also bought and sold shares of TRUP. SBI Securities Co. Ltd. purchased a new position in Trupanion in the 4th quarter worth approximately $25,000. Jones Financial Companies Lllp lifted its stake in Trupanion by 71.7% in the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 238 shares in the last quarter. Quest Partners LLC purchased a new position in Trupanion in the 3rd quarter worth approximately $37,000. Wilmington Savings Fund Society FSB purchased a new position in Trupanion in the 3rd quarter worth approximately $54,000. Finally, KBC Group NV purchased a new position in Trupanion in the 4th quarter worth approximately $75,000.

Wall Street Analyst Weigh In

A number of research firms have weighed in on TRUP. Stifel Nicolaus decreased their target price on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Piper Sandler reduced their price target on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Trupanion currently has an average rating of “Moderate Buy” and a consensus target price of $46.60.

Trupanion Stock Down 0.7 %

TRUP stock opened at $35.83 on Wednesday. The firm has a market cap of $1.52 billion, a PE ratio of -155.78, a PEG ratio of 6.02 and a beta of 1.70. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. The firm’s 50 day moving average price is $42.15 and its 200-day moving average price is $46.90. Trupanion, Inc. has a one year low of $19.69 and a one year high of $57.90.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). The firm had revenue of $337.31 million for the quarter, compared to analysts’ expectations of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. On average, equities research analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.

Insider Buying and Selling at Trupanion

In other Trupanion news, insider Brenna Mcgibney sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $32.99, for a total value of $164,950.00. Following the sale, the insider now owns 3,738 shares of the company’s stock, valued at $123,316.62. The trade was a 57.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Fawwad Qureshi sold 1,373 shares of the business’s stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the completion of the sale, the chief financial officer now directly owns 2,416 shares in the company, valued at approximately $82,675.52. The trade was a 36.24 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 25,984 shares of company stock valued at $850,362 over the last quarter. 5.50% of the stock is owned by company insiders.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.